CLINICAL_TRIALS
trial_result
· 2022-12-22
Clinical Trial Update: AD109 Dose Finding in Mild to Moderate OSA [Phase 2]
Summary
Phase 2 dose-finding trial for AD109 in adults with mild to moderate obstructive sleep apnea has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Apnimed | Conditions: Obstructive Sleep Apnea | Phase 2 | Status: COMPLETED | Results posted: 2022-12-22